BBLG
Bone Biologics
BBLG
BBLG
4 hedge funds and large institutions have $1.83K invested in Bone Biologics in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Holders
4
Holding in Top 10
–
Calls
–
Puts
–
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
1
Tower Research Capital (TRC)
New York
| $806 |
|
|||
|
CS
2
Clear Street
New York
| $556 |
|
|||
3
UBS Group
Zurich,
Switzerland
| $455 |
|
|||
4
Bank of America
Charlotte,
North Carolina
| $16 |
|
|||
5
Geode Capital Management
Boston,
Massachusetts
| – |
|
|||
|
SS
6
SBI Securities
Tokyo,
Japan
| – |
|